Maternal Hemoglobin Levels During Pregnancy: A Predictor of Newborn TSH Levels in Hypothyroid Screening
This study, presented by Dr. Nasim Ebadati, examines the potential link between maternal hemoglobin levels during pregnancy and newborn TSH levels, a key marker in congenital hypothyroidism screening. By investigating maternal hemoglobin levels during the first and second trimesters, the research aims to provide insight into predictive factors that may influence newborn thyroid function, ultimately contributing to more effective prevention and early identification of hypothyroidism in infants.
Presenter: Dr. Nasim Ebadati Project Necessity Summary: Congenital hypothyroidism in children can result in substantial developmental and physical growth impairments. Timely identification through newborn screening using filter paper has the potential to mitigate these complications. It is imperative to comprehend the factors associated with hypothyroidism's development for the purposes of prevention and prediction. Maternal factors, specifically maternal hemoglobin levels during pregnancy, may impact this process; however, the correlation between maternal hemoglobin levels during pregnancy and TSH levels in newborns has not been definitively established. The study aims to investigate the relationship between maternal hemoglobin levels during pregnancy and newborn TSH levels. It will involve full-term infants and analyze maternal hemoglobin levels in the first and second trimesters. If the sample size is not met, infants from nearby health centers or previous years will be included.
comment